Abstract:Introduction: Recent evidence supports the contribution of gut microbiota dysbiosis to the pathophysiology of rheumatic diseases, neuropathic pain, and neurodegenerative disorders. The bidirectional gut-brain communication network and the occurrence of chronic pain both involve contributions of the autonomic nervous system and the hypothalamic pituitary adrenal axis. Nevertheless, the current understanding of the association between gut microbiota and chronic pain is still not clear. Therefore, the aim of this study is to systematically evaluate the existing knowledge about gut microbiota alterations in chronic pain conditions. Methods: Four databases were consulted for this systematic literature review: PubMed, Web of Science, Scopus, and Embase. The Newcastle-Ottawa Scale was used to assess the risk of bias. The study protocol was prospectively registered at the International prospective register of systematic reviews (PROSPERO, CRD42023430115). Alpha-diversity, β-diversity, and relative abundance at different taxonomic levels were summarized qualitatively, and quantitatively if possible. Results: The initial database search identified a total of 3544 unique studies, of which 21 studies were eventually included in the systematic review and 11 in the meta-analysis. Decreases in alpha-diversity were revealed in chronic pain patients compared to controls for several metrics: observed species (SMD= -0.201, 95% CI from -0.04 to -0.36, p=0.01), Shannon index (SMD= -0.27, 95% CI from -0.11 to -0.43, p<0.001), and faith phylogenetic diversity (SMD -0.35, 95% CI from -0.08 to -0.61, p=0.01). Inconsistent results were revealed for beta-diversity. A decrease in the relative abundance of the Lachnospiraceae family, genus Faecalibacterium and Roseburia , and species of Faecalibacterium prausnitzii and Odoribacter splanchnicus , as well as an increase in Eggerthella spp., was revealed in chronic pain patients compared to controls. Discussion: Indications for gut microbiota dysbiosis were revealed in chronic pain patients, with non-specific disease alterations of microbes. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42023430115.

Research progress of gut microflora disorder with chronic pain-related diseases

New Progress in Basic Research of Macrophages in the Pathogenesis and Treatment of Low Back Pain

Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies

Application progress of glucocorticoids in the management of refractory cancer pain

Research Progress on the Correlation Between Chronic Constipation and the Gut Microbiota in the Elderly

Advances in the Research and Treatment of Spinal Endogenous Abdominal Pain

Research progress on cerebral engram cells in chronic pain

Research progress of pain related genes

Knowing the Neuronal Mechanism of Spontaneous Pain to Treat Chronic Pain in the Future.

Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy

Research hotspots and trends in visceral pain research: A global comprehensive bibliometric analysis

The Gut Microbiota and Chronic Pain

Research progress of home self-management support methods for cancer pain patients

Research progress in the relationship between gut microbiome and human diseases

Microbiota-Pain Association; Recent Discoveries and Research Progress

[Research progress on the correlation between autoimmune diseases of the nervous system and intestinal flora]

Research hotspots and trend analysis of abdominal pain in inflammatory bowel disease: A bibliometric and visualized analysis

Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis

Spinal Microglia and Astrocytes: Two Key Players in Chronic Visceral Pain Pathogenesis

The interplay between the microbiota and opioid in the treatment of neuropathic pain

Enterochromaffin Cells: Sentinels to Gut Microbiota in Hyperalgesia?